Evaluation of Quality of Life, Anxiety and Depression in Patients with Alopecia Areata: A Prospective Case-Control Study
September 2025
in “
Cyprus Journal of Medical Sciences
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → 
Studysummary In this study, patients with acute alopecia areata experienced significantly higher anxiety and depression levels, along with a worsened quality of life, compared to a control group, underscoring the importance for clinicians to address these psychiatric issues early in the condition.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This study evaluated the psychosocial impact of alopecia areata (AA) on patients by comparing 70 individuals with AA to 70 matched controls. The results showed that patients with AA had significantly higher anxiety and depression scores, as well as a greater impact on their quality of life, as measured by the hospital anxiety and depression scale (HADS) and the dermatology life quality index (DLQI). The findings highlight the importance for clinicians to identify and manage psychiatric comorbidities in patients with AA, even in the early stages of the condition.
